Enhanced penetrative siRNA delivery by a nanodiamond drug delivery platform against hepatocellular carcinoma 3D models
Jingru Xu(National University of Singapore), Edward Kai‐Hua Chow(National University of Singapore)
Cited by 42
Related Papers
Enabling Technologies for Personalized and Precision Medicine
|Trends in biotechnology|2020|483
Rational drug combination design in patient-derived avatars reveals effective inhibition of hepatocellular carcinoma with proteasome and CDK inhibitors
|Journal of Experimental & Clinical Cancer Research|2022|32
Frequent upregulation of G9a promotes RelB-dependent proliferation and survival in multiple myeloma
|Experimental Hematology and Oncology|2020|21
Histone‐lysine N‐methyltransferase <i>EHMT2</i> (G9a) inhibition mitigates tumorigenicity in Myc‐driven liver cancer
|Molecular Oncology|2023|18
Combinatorial functionomics identifies HDAC6-dependent molecular vulnerability of radioresistant head and neck cancer
|Experimental Hematology and Oncology|2025|3